The agency said all tests for the virus must pass through its EUA process, but noted a test could be authorized under a single EUA for use in multiple labs.
Aiming to improve patient access to critical drugs and tests, a group of legislators have started a caucus to shore up bipartisan support for personalized medicine.
The specimen discard technology automatically and passively "sidelines" potential contaminants during the blood culture collection process, Kurin said.
